Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance

To determine the efficacy of pioglitazone to prevent type 2 diabetes in older compared to younger adults with pre-diabetes. Six hundred two participants with impaired glucose tolerance (IGT) were randomized in double blind fashion to placebo or pioglitazone for diabetes prevention in the ACT NOW stu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Age (Dordr)
Hlavní autoři: Espinoza, Sara E., Wang, Chen-pin, Tripathy, Devjit, Clement, Stephen C., Schwenke, Dawn C., Banerji, Mary Ann, Bray, George A., Buchanan, Thomas A., Henry, Robert R., Kitabchi, Abbas E., Mudaliar, Sunder, Stentz, Frankie B., Reaven, Peter D., DeFronzo, Ralph A., Musi, Nicolas
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2016
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266219/
https://ncbi.nlm.nih.gov/pubmed/27585671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11357-016-9946-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky